Home  /  Resource Library  /  Is Autologous Transplant in Relapsed DLBCL Patients Achieving Only a PET+ PR Appropriate in the CAR-T cell Era?

Is Autologous Transplant in Relapsed DLBCL Patients Achieving Only a PET+ PR Appropriate in the CAR-T cell Era?

Study investigated autologous stem cell transplant for treatment of relapsed diffuse large b-cell lymphoma. (Abstract only)